Curcuwin Ultra+ offers low dose, highly bioavailable curcumin with low cost-in-use.
OmniActive Health Technologies (Morristown, NJ) launched Curcuwin Ultra+, a clinically studied, natural joint-health ingredient that is efficacious at a low dose with an excellent organoleptic profile. This allows for its use in challenging applications such as gummies and beverages, and a low cost-in-use.
“It’s no news that curcumin is still wildly popular with consumers, and as their demands evolved, we saw that there were multiple gaps arising in the market,” said Sayantan Bhattacharya, senior director, category manager who oversees OmniActive’s branded curcumin products, in a press release. “Curcuwin Ultra+ addresses several of these challenges in a single, convenient ingredient.”
Curcuwin Ultra+ uses a specialized process that incorporates bioenhancers to better protect and deliver more curcuminoids than standard curcumin. According to Omniactive, a clinical study found that the ingredient was 144x more bioavailable compared to standard curcumin. Because it is made using Ultrasol, the same foundational technology as its predecessor, Curcumin Ultra+ also comes with the same clinically supported heart health and sports nutrition benefits as the original Curcuwin.
“This product aims at disrupting how brands formulate with curcumin in an era where consumers are constantly looking at convenient solutions that can deliver more for less,” said Isabel Lucas, director of product launch and marketing excellence, for OmniActive. “We believe people will be highly interested in Curcuwin Ultra+ because of its clinically demonstrated bioavailability and that it addresses consumer needs in the joint health, sports nutrition and active wellness markets.”
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.